FindTrial
Sign In

Blood Transfusion Support For Patients With Antibodies Against Self Red Cell Antigens

Prospective Study On Serological Characterization Of Autoimmune Hemolytic Anemia And Selection Of Optimal Blood For Transfusion In A Tertiary Care Hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/01/022750
Enrollment
100
Registered
2020-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D591- Other autoimmune hemolytic anemias

Interventions

Intervention1: NIL: NIL Control Intervention1: Nil: Nil

Sponsors

Kasturba Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All blood samples referred for Direct Antiglobulin Test

Exclusion criteria

Exclusion criteria: 1.Neonatal Direct Anti globulin Test samples 2.Samples received for DAT from outside hospitals

Design outcomes

Primary

MeasureTime frame
This study helps in identifying the best matched blood and study the efficacy of transfused blood product in AIHA patients. Timepoint: At the time of issue of blood product—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Fathima Urooj

Kasturba Medical College ,Manipal Academy of Higher Education, Madhavnagar, Manipal

shameeshastry@gmail.com0820-2922331

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026